Metabolic flux analysis for calcium dependent antibiotic (CDA) production in Streptomyces coelicolor
- 31 October 2004
- journal article
- Published by Elsevier in Metabolic Engineering
- Vol. 6 (4) , 313-325
- https://doi.org/10.1016/j.ymben.2004.04.001
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Structure, Biosynthetic Origin, and Engineered Biosynthesis of Calcium-Dependent Antibiotics from Streptomyces coelicolorChemistry & Biology, 2002
- Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)Nature, 2002
- Forty years of genetics with Streptomyces: from in vivo through in vitro to in silicoMicrobiology, 1999
- Harnessing the Biosynthetic Code: Combinations, Permutations, and MutationsScience, 1998
- Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetiusNature Biotechnology, 1998
- Physical identification of a chromosomal locus encoding biosynthetic genes for the lipopeptide calcium-dependent antibiotic (CDA) of Streptomyces coelicolor A3(2)Microbiology, 1998
- Genetic Contributions to Understanding Polyketide SynthasesChemical Reviews, 1997
- Harnessing the Biosynthetic Potential of Modular Polyketide SynthasesChemical Reviews, 1997
- CDA: Calcium‐Dependent Peptide Antibiotics from Streptomyces coelicolor A3(2) Containing Unusual ResiduesAngewandte Chemie International Edition in English, 1997
- Production of ‘hybrid’ antibiotics by genetic engineeringNature, 1985